New U.S. clinical trial outcomes indicate experimental therapy may not only work against small fiber neuropathy, but also improve chronic fatgue and quality of life in sarcoidosis.

For clinical trial outcomes in study among U.S. sarcoidosis patients, see: http://araimpharma.com/wp-content/uploads/2017/05/ARAIM_DOSARA_Release_05-08-2017.pdf

See also this publication by Dr. Daniel Culver (Cleveland Clinic), which suggests that Cibinetide may improve chronic fatigue and improve quality of life for sarcoidosis patients: https://www.ncbi.nlm.nih.gov/m/pubmed/28475703/